Rapid Micro Biosystems logo
Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results
11 nov. 2021 18h15 HE | Rapid Micro Biosystems, Inc.
Reports third quarter 2021 total revenue of $6.9 million and commercial revenue of $6.3 million Reaffirms full-year 2021 commercial revenue outlook of at least $24.0 million, representing at least...
22157.jpg
Global Clinical In Vitro Diagnostic Medical Laboratory Services Market Report: COVID Testing Accelerates Shift to Molecular Diagnostics
05 nov. 2021 05h28 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market Report 2022 - 2026" report has been added to ResearchAndMarkets.com's offering. ...
LOGO.jpg
Save Foods to Pursue Further and Larger Scale Research Collaboration with the University of California, Riverside
04 nov. 2021 08h15 HE | Save Foods Inc
The decision to increase collaboration was made by the Company’s Board following the successful validation study conducted in the field by Dr. Jim Adaskaveg, a key opinion leader and professor at the...
Rapid Micro Biosystems logo
Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference
29 oct. 2021 07h30 HE | Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Candida + auris
Hardy Diagnostics Releases HardyCHROM™ Candida + auris
20 oct. 2021 06h00 HE | Hardy Diagnostics
SANTA MARIA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Hardy Diagnostics is pleased to announce its release of HardyCHROM™ Candida + auris, a chromogenic media recommended for the selective...
Rapid Micro Biosystems logo
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
19 oct. 2021 07h30 HE | Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
22157.jpg
Global Clinical In Vitro Diagnostic Medical Laboratory Services Markets 2021-2025 - Alternative Medicine Creates Testing Opportunity & Genetic Based Testing Creates New Department and New Discipline
14 oct. 2021 04h53 HE | Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market, Q4 2021" report has been added to ResearchAndMarkets.com's offering. The...
Rapid Micro Biosystems logo
Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer
05 oct. 2021 17h15 HE | Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation...
Join!
Hardy Diagnostics Presents: Detection of Carbapenemase Producing Organisms; Advancements and Barriers to the Clinical Laboratory
21 sept. 2021 06h00 HE | Hardy Diagnostics
SANTA MARIA, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Carbapenemase-resistant Enterobacterales (CRE) are a major concern for patients in health care facilities. Some bacteria in this family are...
22157.jpg
Global In Vitro Diagnostics Quality Control Market (2021 to 2026) - Rising Demand for Multi-analyte Controls Presents Opportunities
16 sept. 2021 07h38 HE | Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Quality Control Market, by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology,...